India  

Novavax

American biotechnology company

Novavax    ▸ Facts   ▸ Comments   ▸ News   ▸ Videos   

Novavax: American biotechnology company
Novavax, Inc. is an American biotechnology company based in Gaithersburg, Maryland that develops vaccines to counter serious infectious diseases. Prior to 2020, company scientists developed experimental vaccines for influenza and respiratory syncytial virus (RSV), as well as Ebola and other emerging infectious diseases. During 2020, the company redirected its efforts to focus on development and approval of its NVX-CoV2373 vaccine for COVID-19.

0
shares
ShareTweetSavePostSend
 

You Might Like


WHO approves SII's Covovax for emergency use

Covavax is the Indian version of the Novavax vaccine brought in India by the Serum Institute of India for children.
DNA - Published

Novavax Covid-19 vaccine receives first emergency use authorization

Novavax Inc and partner Serum Institute of India said on Monday they received emergency use authorization for their Covid-19 vaccine in Indonesia, making it the first approval anywhere in the world for..
IndiaTimes - Published

Search this site and the web: